Screening pesticides for neuropathogenicity

Journal of Biomedicine and Biotechnology

Volumn 2006, Issue , 2006, Pages

  Doherty, John D ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBICIDE; MANEB; ORGANOPHOSPHATE; PARAQUAT; PESTICIDE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; DEGENERATIVE DISEASE; EXPERIMENTAL ANIMAL; HUMAN; MENTAL DISEASE; NEUROPATHOLOGY; NEUROPATHY; NEUROTOXICITY; NONHUMAN; ORGANOPHOSPHATE INDUCED DELAYED NEUROPATHY; PARKINSONISM; PRACTICE GUIDELINE; RISK FACTOR; SCREENING; SHORT SURVEY;

ANIMALIA;

EID: 40549102190     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/JBB/2006/70414     Document Type: Short Survey

References (58)

1. Langston J W, The etiology of Parkinson's disease with emphasis on the MPTP story Neurology 1996 47 6 suppl 3 S153 S160
2. Chu N-S, Huang C-C, Calne D B, Spencer P S, Schaumburg H H, Ludolph A C, Manganese Experimental and Clinical Neurotoxicology 2000 2nd New York, NY Oxford Press 752 755
3. Kiely T, Donaldson D, Grube A, Pesticide Industry Sales and Usage: 2000 and 2001 Market Estimates 2004. Published by Biological and Economic Analysis Division, Office of Pesticide Programs Office of Prevention, Pesticides and Toxic Substances, U.S. Environmental Protection Agency, Washington, DC 20460
4. Ecobichon D J, Klassen C D, Toxic effects of pesticides Casarett and Doull's Toxicology: The Basic Science of Poisons 1996 5th New York, NY McGraw Hill 643 689
5. EPA. 1998. OPPTS Harmonized Test Guidelines Series 870 Health Effects. United States Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, Washington, DC. 20460. http://www.epa.gov/pesticides (See under Science and Policy- Test Guidelines)
6. EPA. 2002. A Review of the reference dose and reference concentration processes. Risk Assessment Forum Report dated December 2002
7. Cory-Slechta D A, Thiruchelvam M, Barlow B K, Richfield E K, Developmental pesticide models of the Parkinson disease phenotype Environmental Health Perspectives 2005 113 9 1263 1270
8. Liou H H, Tsai M C, Chen C J, Environmental risk factors and Parkinson's disease: a case-control study in Taiwan Neurology 1997 48 6 1583 1588
9. Woodward G, Autism and Parkinson's disease Medical Hypotheses 2001 56 2 246 249
10. Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues J-F, Brochard P, Neurodegenerative diseases and exposure to pesticides in the elderly American Journal of Epidemiology 2003 157 5 409 414
11. Barlow B K, Richfield E K, Cory-Slechta D A, Thiruchelvam M, A fetal risk factor for Parkinson's disease Developmental Neuroscience 2004 26 1 11 23
12. Firestone J A, Smith-Weller T, Franklin G, Swanson P, Longstreth W T Jr, Checkoway H, Pesticides and risk of Parkinson disease: a population-based case-control study Archives of Neurology 2005 62 1 91 95
13. Takahashi R N, Rogerio R, Zanin M, Maneb enhances MPTP neurotoxicity in mice Research Communications in Chemical Pathology and Pharmacology 1989 66 1 167 170
14. Walters T L, Irwin I, Delfani K, Langston J W, Janson A M, Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP Experimental Neurology 1999 156 1 62 70
15. Sherer T B, Kim J-H, Betarbet R, Greenamyre J T, Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation Experimental Neurology 2003 179 1 9 16
16. Betarbet R, Sherer T B, MacKenzie G, Garcia-Osuna M, Panov A V, Greenamyre J T, Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience 2000 3 12 1301 1306
17. Sherer T B, Betarbet R, Stout A K, An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage Journal of Neuroscience 2002 22 16 7006 7015
18. Doherty J D, Salem N Jr, Lauter C J, Trams E G, Mn 2 + -stimulated ATPase in rat brain Neurochemical Research 1983 8 4 493 500
19. Fleming L, Mann J B, Bean J, Briggle T, Sanchez-Ramos J R, Parkinson's disease and brain levels of organochlorine pesticides Annals of Neurology 1994 36 1 100 103
20. Miller G W, Kirby M L, Levey A I, Bloomquist J R, Heptachlor alters expression and function of dopamine transporters NeuroToxicology 1999 20 4 631 637
21. Corrigan F M, Wienburg C L, Shore R F, Daniel S E, Mann D, Organochlorine insecticides in substantia nigra in Parkinson's disease Journal of Toxicology and Environmental Health-Part A 2000 59 4 229 234
22. Di Monte D A, The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurology 2003 2 9 531 538
23. Cannas A, Costa B, Tacconi P, Pinna L, Fiaschi A, Dementia of Alzheimer type (DAT) in a man chronically exposed to pesticides Acta Neurologica 1992 14 3 220 223
24. Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D, Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study Environmental Research 2001 86 1 37 45
25. Burns C J, Beard K K, Cartmill J B, Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945-94: an update Occupational and Environmental Medicine 2001 58 1 24 30
26. McGuire V, Longstreth W T Jr, Nelson L M, Occupational exposures and amyotrophic lateral sclerosis: a population- based case-control study American Journal of Epidemiology 1997 145 12 1076 1088
27. Jamal G A, Hansen S, Julu P OO, Low level exposures to organophosphorus esters may cause neurotoxicity Toxicology 2002 181-182 23 33
28. Van Helden H PM, Vanwersch R AP, Kuijpers W C, Trap H C, Philippens I HC, Benschop H P, Low levels of sarin affect the EEG in marmoset monkeys: a pilot study Journal of Applied Toxicology 2004 24 6 475 483
29. Duffy F H, Burchfiel J L, Bartels P H, Gaon M, Sim V M, Long-term effects of an organophosphate upon the human electroencephalogram Toxicology and Applied Pharmacology 1979 47 1 161 176
30. Shu X O, Linet M S, Gao R N, Chloramphenicol use and childhood leukaemia in Shanghai Lancet 1987 2 8565 934 937
31. Maurissen J P, Marable B R, Neurotoxicity test validation, positive controls and proficiency: are chemicals necessary? Neurotoxicology and Teratology 2005 27 4 545 551
32. Abou-Donia M B, Organophosphorus ester-induced chronic neurotoxicity Archives of Environmental Health 2003 58 8 484 497
33. Smith M I, Lillie R D, The histopathology of triorthocresyl phosphate poisoning. The etiology of so-called ginger paralysis (third report) Archives of Neurology and Psychiatry 1931 26 976 992
34. Bidstrup P L, Bonnell J A, Beckett A G, Paralysis following poisoning by a new organic phosphorus insecticide (mipafox); report on two cases British Medical Journal 1953 1 4819 1068 1072
35. Abou-Donia M B, Organophosphorus ester-induced delayed neurotoxicity Annual Review of Pharmacology and Toxicology 1981 21 511 548
36. Xintaris C, Burg J R, Tanaka S, Occupational exposure to leptophos and other chemicals 1978. Washington, DC, DHEW (NIOSH) Publication no.: 78-136. US Government Printing Office
37. Johnson M K, Delayed neurotoxicity tests of organophosphorus esters: a proposed protocol integrating neuropathy target esterase (NTE) assays with behavior and histopathology tests to obtain more information more quickly from fewer animals 1 Proceedings of the International Congress on Environmental Hazards of Agrochemicals in Developing Countries 1983 Alexandria, Egypt 474 493
38. Johnson M K, Barnes J M, Age and the sensitivity of chicks to the delayed neurotoxic effects on some organophosphorus compounds Biochemical Pharmacology 1970 19 12 3045 3047
39. De Oliveira G H, Moreira V, Goes S PR, Organophosphate induced delayed neuropathy in genetically dissimilar chickens: studies with tri- ortho -cresyl phosphate (TOCP) and trichlorfon Toxicology Letters 2002 136 2 143 150
40. Parkinson's Disease Foundation. 2004. Symptoms, http://www.pdf.org/ AboutPD/symptoms.cfm
41. Dawson T M, Dawson V L, Molecular pathways of neurodegeneration in Parkinson's disease Science 2003 302 5646 819 822
42. Tanner C M, Ottman R, Goldman S M, Parkinson disease in twins: an etiologic study Journal of the American Medical Association 1999 281 4 341 346
43. Li A A, Mink P J, McIntosh L J, Teta M J, Finley B, Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease Journal of Occupational and Environmental Medicine 2005 47 10 1059 1087
44. Uversky V N, Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration Cell and Tissue Research 2004 318 1 225 241
45. Bové J, Prou D, Perier C, Przedborski S, Toxin-induced models of Parkinson's disease NeuroRx 2005 2 3 484 494
46. Fleming S M, Fernagut P-O, Chesselet M-F, Genetic mouse models of Parkinsonism: strengths and limitations NeuroRx 2005 2 3 495 503
47. Chesselet M-F, Animal models of neurological disorders (an editorial) NeuroRx 2005 2 3 395
48. Richardson J R, Quan Y, Sherer T B, Greenamyre J T, Miller G W, Paraquat neurotoxicity is distinct from that of MPTP and rotenone Toxicological Sciences 2005 88 1 193 201
49. Thiruchelvam M, Richfield E K, Goodman B M, Baggs R B, Cory-Slechta D A, Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype NeuroToxicology 2002 23 4-5 621 633
50. Landrigan P J, Sonawane B, Butler R N, Trasande L, Callan R, Droller D, Early environmental origins of neurodegenerative disease in later life Environmental Health Perspectives 2005 113 9 1230 1233
51. Logroscino G, The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environmental Health Perspectives 2005 113 9 1234 1238
52. Gatz M, Reynolds C A, Fratiglioni L, Role of genes and environments for explaining Alzheimer disease Archives of General Psychiatry 2006 63 2 168 174
53. Spires T L, Hyman B T, Transgenic models of Alzheimer's disease: learning from animals NeuroRx 2005 2 3 423 437
54. Scarmeas N, Albert S M, Manly J J, Stern Y, Education and rates of cognitive decline in incident Alzheimer's disease Journal of Neurology, Neurosurgery and Psychiatry 2006 77 3 308 316
55. Schneider T, Przewlocki R, Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism Neuropsychopharmacology 2005 30 1 80 89
56. Miyaki K, Nishiwaki Y, Maekawa K, Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack Journal of Occupational Health 2005 47 4 299 304
57. Kawada T, Katsumata M, Suzuki H, Insomnia as a sequela of sarin toxicity several years after exposure in Tokyo subway trains Perceptual and Motor Skills 2005 100 3 II 1121 1126
58. Ohtani T, Iwanami A, Kasai K, Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study Psychiatry and Clinical Neurosciences 2004 58 6 624 629